← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

M

$ Value

$32K

Shares

13,000

Price

$2

Filed

Dec 23

Insider

Name

Hohl Benjamin

Title

CHIEF FINANCIAL OFFICER

CIK

0001882764

Roles

Officer

Transaction Details

Transaction Date

2025-12-22

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

36,000

Footnotes

All of the shares subject to this option are fully vested and exercisable as of the date hereof.

Filing Info

Accession No.

0001882764-25-000005

Form Type

4

Issuer CIK

0001672619

Hohl Benjamin's History

Date Ticker Type Value
2026-03-06 ELVN $296K
2026-02-12 ELVN A $0
2026-02-12 ELVN A $0
2025-12-22 ELVN M $32K
2025-12-22 ELVN M $0
2025-09-29 ELVN M $8K
2025-09-29 ELVN $66K
2025-09-29 ELVN M $0
2025-08-27 ELVN M $8K
2025-08-27 ELVN $67K

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12